Glucose targets for preventing diabetic kidney disease and its progression

BACKGROUND: Diabetes is the leading cause of end‐stage kidney disease (ESKD) around the world. Blood pressure lowering and glucose control are used to reduce diabetes‐associated disability including kidney failure. However there is a lack of an overall evidence summary of the optimal target range fo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: Ruospo, Marinella, Saglimbene, Valeria M, Palmer, Suetonia C, De Cosmo, Salvatore, Pacilli, Antonio, Lamacchia, Olga, Cignarelli, Mauro, Fioretto, Paola, Vecchio, Mariacristina, Craig, Jonathan C, Strippoli, Giovanni FM
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2017
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6481869/
https://ncbi.nlm.nih.gov/pubmed/28594069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010137.pub2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados